PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,552,000 | +31.2% | 40,000 | +100.0% | 0.57% | +25.7% |
| Q2 2018 | $1,183,000 | -30.5% | 20,000 | -20.0% | 0.46% | -42.7% |
| Q1 2018 | $1,701,000 | -50.8% | 25,000 | -28.6% | 0.79% | -38.2% |
| Q4 2017 | $3,460,000 | +44.5% | 35,000 | +75.0% | 1.28% | +57.5% |
| Q3 2017 | $2,395,000 | +37.0% | 20,000 | 0.0% | 0.82% | +27.3% |
| Q2 2017 | $1,748,000 | +56.6% | 20,000 | -33.3% | 0.64% | +23.1% |
| Q1 2017 | $1,116,000 | +21.2% | 30,000 | 0.0% | 0.52% | +18.5% |
| Q4 2016 | $921,000 | – | 30,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |